Carmichael Hill & Associates’s ContraFect Corporation CFRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1
Closed -$1 829
2023
Q3
$1 Hold
1
﹤0.01% 791
2023
Q2
$2 Hold
1
﹤0.01% 790
2023
Q1
$2 Hold
1
﹤0.01% 780
2022
Q4
$10 Hold
1
﹤0.01% 781
2022
Q3
$0 Hold
1
﹤0.01% 884
2022
Q2
$0 Hold
1
﹤0.01% 886
2022
Q1
$0 Hold
1
﹤0.01% 855
2021
Q4
$0 Hold
1
﹤0.01% 851
2021
Q3
$0 Hold
1
﹤0.01% 831
2021
Q2
$0 Hold
1
﹤0.01% 805
2021
Q1
$0 Sell
1
-1
-50% -$431 ﹤0.01% 794
2020
Q4
$1K Hold
2
﹤0.01% 733
2020
Q3
$1K Buy
2
+1
+100% +$454 ﹤0.01% 708
2020
Q2
$1K Buy
+1
New +$491 ﹤0.01% 687

Other funds holding CFRX

Carmichael Hill & Associates's CFRX Position: Q4 2023 in Review

Carmichael Hill & Associates sold out of ContraFect Corporation (CFRX) in Q4 2023, closing a stake of 1 share — an estimated $1 sold.

Carmichael Hill & Associates first reported a position in CFRX in Q2 2020 and held it in 14 quarters. The position peaked at $1K in Q4 2020. 2 funds tracked by Wall St. Rank hold CFRX as of Q4 2023.

  • Carmichael Hill & Associates reported no remaining ContraFect Corporation position as of Q4 2023 after selling out during the quarter.
  • Carmichael Hill & Associates sold 1 ContraFect Corporation share in Q4 2023, an estimated $1.
  • Carmichael Hill & Associates first reported a position in ContraFect Corporation in Q2 2020 and held it in 14 quarters.
  • Carmichael Hill & Associates's ContraFect Corporation position peaked at $1K in Q4 2020.
  • 2 funds tracked by Wall St. Rank held ContraFect Corporation as of Q4 2023.

Based on Carmichael Hill & Associates's 13F filing for Q4 2023, filed 23 Jan 2024.